🇺🇸 FDA
Patent

US 10106792

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

granted A61PA61P1/00A61P1/02

Quick answer

US patent 10106792 (Methods and compositions for the specific inhibition of gene expression by double-stranded RNA) held by INTEGRATED DNA TECHNOLOGIES, INC. expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INTEGRATED DNA TECHNOLOGIES, INC.
Grant date
Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16